Bionano Genomics, Inc. (BNGO)

NASDAQ: BNGO · USD

$1.20

-0.02 (-1.6%)· Recorded snapshot

Market cap	14.1M
Revenue (ttm)	30.2M
Net income (ttm)	-32.2M
EPS (ttm)	-$3.37
Shares out	11.8M
Volume	110,131
Beta	1.66

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 30.2M
Net income (ttm): -32.2M
EPS (ttm): -$3.37
Market cap: 14.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-83.6

P25 n/aP50 n/aP75 n/a

ROIC-39

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BNGO indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001411690
Company name	Bionano Genomics, Inc.
Country	United States
Country code	US
CUSIP number	09075F404
Earnings date	2026-11-10
Earnings time	amc
Employees	97
Employees change	-3
Employees growth	-3%
Enterprise value	$10.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	Medical Instruments & Supplies
IPO date	2018-08-21
Is primary listing	Yes
Is SPAC	No
ISIN number	US09075F4046
Last 10-K release date	2026-03-23
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2025-01-27
Last stock split type	Reverse
Market cap	$14.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	No
Price	$1.20
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	BNGO
U.S. state	California
Website	https://bionano.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-280.89%
EV/Sales	0.37x
FCF / EV yield	-182.66%
FCF yield	-141.95%
Forward EV/Sales	0.31x
Forward P/S	0.4x
Industry forward P/E	22.69x
Industry P/E	75.18x
P/B ratio	0.45x
P/S ratio	0.48x
Price / tangible book value	0.48x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-106.68%
EBITDA margin	-75.12%
Gross margin	47.5%
Operating margin	-106.68%
Pretax margin	-106.37%
Profit margin	-106.58%
Profit per employee	$-331,577
Revenue per employee	$311,093
ROA	-32.56%
ROA (5Y)	-28.72%
ROCE	-85.73%
ROE	-83.56%
ROE (5Y)	-91.04%
ROIC	-38.97%
SBC / revenue	11.62%
Tax / revenue	0.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	11
EPS growth years	2
Gross profit growth	932.78%
Gross profit growth (Q)	24.07%
Gross profit growth 3Y	21.51%
Gross profit growth 5Y	26.67%
Net income growth years	2
Revenue growth	10.03%
Revenue growth (Q)	21.36%
Revenue growth (QoQ)	22.19%
Revenue growth 3Y	-1.43%
Revenue growth 5Y	17.97%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$9.5M
EBIT	$-32.2M
EBITDA	$-22.7M
EPS	$-3.37
FCF per share	$-1.74
Financing cash flow	$2.6M
Free cash flow	$-20.5M
Free cash flow minus SBC	$-24M
Gross profit	$14.3M
Income taxes	$66,000
Investing cash flow	$18.5M
Net borrowing	$-12.2M
Net cash flow	$669,000
Net income	$-32.2M
Operating cash flow minus SBC	$-24M
Operating income	$-32.2M
Revenue	$30.2M
Stock-based compensation	$3.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-22.31
Book value per share	$2.68
Debt / equity	0.21
Interest coverage	-114.16
Long-term assets	$22.7M
Long-term liabilities	$5.9M
Net cash (debt)	$3.2M
Net cash / market cap	22.28%
Net debt / equity	-0.1
Piotroski F-Score	4
Property, plant and equipment	$18.9M
Shareholders' equity	$31.6M
Tangible book value	$29.9M
Tangible book value per share	$2.54
Total assets	$47.6M
Total cash	$9.9M
Total debt	$6.7M
Total liabilities	$16M
WACC	10.18%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.49
Current assets	$24.9M
Current liabilities	$10M
Current ratio	2.48
Inventory turnover	2.29
Net working capital	$5.8M
Quick ratio	1.42
Working capital	$14.8M
Working capital turnover	1.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-314.06%
Dividend yield	0%
Shareholder yield	-314.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.25
1D price change	-1.64%
1M price change	-27.71%
1M total return	-27.71%
1W price change	-4%
1W total return	-4%
1Y price change	-37.17%
1Y return CAGR	-37.19%
1Y total return	-37.17%
20-day SMA	$1.33
200-day SMA	$1.25
3M price change	11.11%
3M total return	11.11%
3Y price change	-98.41%
3Y return CAGR	-74.86%
3Y total return	-98.41%
50-day SMA	$1.38
50-day SMA vs 200-day SMA	50over200
52-week high	$2.23
52-week high date	2026-09-15
52-week low	$1.00
52-week low date	2026-07-31
5Y price change	-99.96%
5Y return CAGR	-79.13%
5Y total return	-99.96%
6M price change	-2.44%
6M total return	-2.44%
All-time high	$9,413.98
All-time high date	2021-02-16
All-time low	$1.00
All-time low date	2026-07-31
Average true range (ATR)	$0.09
Average volume	220.1K
Beta (1Y)	1.39
Beta (2Y)	1.35
Beta (5Y)	1.66
Change from 52-week high	-46.19%
Change from 52-week low	20%
Change from all-time high	-99.99%
Change from all-time low	20%
Change from open	-2.44%
Day's gap	0.82%
Dollar volume	$132,157
High price	$1.25
Low price	$1.20
Monthly RSI	33.36
Open price	$1.23
Position in 52-week range	0%
Premarket change	0.82%
Premarket close	$1.22
Premarket price	$1.23
Previous close	$1.22
Price vs 150-day SMA	-3.69%
Price vs 20-day SMA	-9.77%
Price vs 200-day SMA	-3.69%
Price vs 50-day SMA	-12.79%
Relative volume	0.5
RSI	38.14
Sharpe ratio	-0.51
Sharpe ratio (3Y)	-1.18
Sharpe ratio (5Y)	-1.34
Sortino ratio	-0.67
Sortino ratio (3Y)	-1.61
Sortino ratio (5Y)	-1.83
Volume	110.1K
Weekly RSI	44.31
YTD price change	-21.57%
YTD total return	-21.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10.6M
Float percentage	90.32%
Shares change (QoQ)	5.16%
Shares change (YoY)	314.06%
Shares held by insiders	0.09%
Shares held by institutions	20.87%
Shares outstanding	11.8M
Short % of float	12.79%
Short % of shares	11.55%
Short ratio	0.9 days

Deeper analysis on BNGO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BNGO report

Is a complete BNGO research report available?

No complete published report is available for Bionano Genomics, Inc. (BNGO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Bionano Genomics, Inc. (BNGO)

Price

Financial snapshot

Fair-value bridge

Latest news · BNGO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNGO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BNGO

Frequently asked questions